NCT02220907 - Long-Term Safety Study of MT-2412 in Japanese Patients With Type 2 Diabetes | Biotech Hunter

Enrollment

153

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Teneligliptin/Canagliflozin

Co-administration of Teneligliptin and Canagliflozin orally once daily for 52 weeks.

Trial Locations (6)

Research site, Chugoku

Research site, Chūbu

Research site, Hokkaido

Research site, Kanto

Research site, Kyushu

Research site, Tōhoku